. . . . . . . "[Halofuginone (HF), a low-molecular-weight alkaloid that modulates TGF? signaling, was used to treat APL cell lines and non-obese diabetic/severe combined immunodeficiency (NOD/SCID) mice subjected to transplantation with leukemic cells from human chorionic gonadotrophin-PML-RAR? transgenic mice (TG).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:12:06+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .